12/20/2019 | December 20, 2019 Approval Letter - MENVEO |
12/20/2019 | December 19, 2019 Approval Letter - ERVEBO |
12/20/2019 | Submitting Study Datasets for Vaccines to the Office of Vaccines Research and Review; Guidance for Industry; Technical Specifications Document |
12/20/2019 | Important Information for Potential Donors of Blood and Blood Products |
12/20/2019 | TRG Rapid Inquiry Program (TRIP) |
12/20/2019 | BK190401 - ZipThaw™ 202 |
12/19/2019 | BK190400 - MTS™ Buffered Gel Card |
12/19/2019 | BK190399 - ORTHO VISION Max Analyzer |
12/19/2019 | Considerations for the Development of Dried Plasma Products Intended for Transfusion; Guidance for Industry |
12/18/2019 | December 17, 2019 Approval Letter - MTS Anti-IgG Card |
12/18/2019 | December 17, 2019 Approval Letter - ORTHO Sera |
12/18/2019 | 2019 Biological Device Application Approvals |
12/18/2019 | 2019 Biological License Application Supplement Noteworthy Approvals |
12/16/2019 | BK190388 - TANGO infinity |
12/12/2019 | Meeting Transcript - Advancing Scientific and Regulatory Approaches for Use and Development of Biomarkers for Preventative Vaccines Meeting - Tuesday, September 17, 2019 |
12/12/2019 | BK190320 - DG Reader |
12/12/2019 | BK190321- WADiana Compact |
12/12/2019 | BK190318 - Erytra |
12/11/2019 | December 10, 2019 - Approval Letter - Anti-D (RH1) IgM/IgG 125621/2 |
12/11/2019 | December 10, 2019 Approval Letter - DG Gel 8 Anti-IgG (Rabbit), DG Gel Cards - STN# 125445/32 |
12/11/2019 | CBER Vacancy: Postdoctoral Fellow/Visiting Associate – Viral Vaccines (Biologist), RG-0401 |
12/9/2019 | Complete List of Licensed Products and Establishments |
12/9/2019 | Complete List of Substantially Equivalent 510(k) Device Applications |
12/9/2019 | Complete List of Currently Approved Premarket Approvals (PMAs) |
12/9/2019 | Complete List of Currently Approved NDA and ANDA Application Submissions |
12/9/2019 | December 6, 2019 Approval Letter - TENIVAC |
12/9/2019 | BK190333 - Terumo Operational Medical Equipment Software (TOMEs), Version 7.1 |
12/9/2019 | CBER-Regulated Products: Current Shortages |
12/6/2019 | Public Safety Notification on Exosome Products |
12/5/2019 | December 3, 2019 Approval Letter - Panoscreen EXTEND |
12/5/2019 | User Fee Billable Biologic Products and Potencies Approved Under Section 351 of PHS Act |
12/5/2019 | Influenza Vaccine for the 2019-2020 Season |
12/5/2019 | Job Vacancy Announcement: Physician, Division of Epidemiology (DE) - Title 38(F) Physician (GP-0602) |
12/4/2019 | December 3, 2019 Approval Letter - Data-Cyte Plus 2, and Data-Cyte Extend 0.8 % Reagent Red Blood Cells |
12/4/2019 | BK190389 - ALBAcheck BGS Monoclonal Control |
12/3/2019 | November 25, 2019 Untitled Letter - Chara Biologics, Inc. |
12/3/2019 | Exceptions and Alternative Procedures Approved Under 21 CFR 640.120 |
12/2/2019 | March 3, 2020 Workshop - Facilitating End-to-End Development of Individualized Therapeutics |
11/29/2019 | November 26, 2019 Approval Letter - Pneumovax 23 |
11/27/2019 | November 25, 2019 Order to Cease Manufacturing - Gynecology, Reproductive Endocrinology and Fertility Institute (GREFI) |
11/27/2019 | Influenza Vaccine for the 2019-2020 Season |
11/25/2019 | FDA Zika virus reference panel for molecular-based diagnostic devices supports product testing for Emergency Use Authorization and 510(k) submissions |
11/22/2019 | November 20, 2019 Untitled Letter - RichSource Stem Cells, Inc. |
11/21/2019 | Influenza Vaccine for the 2019-2020 Season |
No hay comentarios:
Publicar un comentario